David A. Siegel Pds Biotechnology Corp Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$3.95 - $6.58 $562,085 - $936,334
-142,300 Reduced 56.6%
109,100 $542,000
Q3 2023

Nov 14, 2023
SELL
$4.8 - $6.4 $768,000 - $1.02 Million
-160,000 Reduced 38.89%
251,400 $1.27 Million
Q2 2023

Aug 14, 2023
SELL
$5.03 - $9.9 $870,190 - $1.71 Million
-173,000 Reduced 29.6%
411,400 $2.07 Million
Q1 2023

May 15, 2023
BUY
$5.68 - $11.99 $143,136 - $302,148
25,200 Added 4.51%
584,400 $3.59 Million
Q4 2022

Feb 14, 2023
BUY
$3.28 - $13.2 $481,074 - $1.94 Million
146,669 Added 35.55%
559,200 $7.38 Million
Q3 2022

Nov 14, 2022
SELL
$2.97 - $5.79 $388,383 - $757,152
-130,769 Reduced 24.07%
412,531 $1.23 Million
Q2 2022

Aug 15, 2022
BUY
$3.05 - $6.68 $33,550 - $73,480
11,000 Added 2.07%
543,300 $1.98 Million
Q1 2022

May 16, 2022
BUY
$4.78 - $8.43 $25,812 - $45,522
5,400 Added 1.02%
532,300 $3.3 Million
Q4 2021

Feb 14, 2022
BUY
$7.76 - $14.35 $376,360 - $695,975
48,500 Added 10.14%
526,900 $4.27 Million
Q3 2021

Nov 15, 2021
BUY
$9.33 - $17.08 $4.46 Million - $8.17 Million
478,400 New
478,400 $7.13 Million
Q3 2020

Nov 16, 2020
SELL
$1.67 - $4.67 $54,776 - $153,176
-32,800 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.65 - $2.6 $21,320 - $85,280
32,800 New
32,800 $66,000

Others Institutions Holding PDSB

# of Institutions
64
Shares Held
4.32M
Call Options Held
253K
Put Options Held
70.4K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $62.6M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email